Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
Clinical trial NCT00064142 · COMPLETED
Trial details
- NCT number
- NCT00064142
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Primary completion
- 2006-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.